Breaking News, Collaborations & Alliances

Tedor Pharma, Cardinal Health Form Collaboration

To deliver regulatory solutions for biopharma manufacturing compliance

Tedor Pharma and Cardinal Health Regulatory Sciences have formed a collaboration to deliver integrated regulatory solutions to meet the needs of the evolving manufacturing compliance environment in the biopharmaceutical industry.
 
The agreement leverages the regulatory consulting expertise of Cardinal Health and Tedor’s oral solid dose manufacturing capabilities and exclusive North American drug delivery technologies.
 
“Bringing together the deep industry expertise of Cardinal Health Regulatory Sciences with Tedor’s collaborative approach in contract development and manufacturing will be transformative for our clients,” said Doug Drysdale, president and chief executive officer, Tedor.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters